For the past few years, the buzz around drugs termed rather technically GLP-1 agonists has been deafening. That stands for glucagon-like peptide 1 receptor agonists, so we trust you won’t mind the ...

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...

Finding natural ways to increase glucagon-like peptide-1, otherwise known as GLP-1, can be very beneficial in helping treat type 2 diabetes and obesity. The Biedenharn Museum and Gardens is hosting a ...

Among U.S. adults without diabetes, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) increased from 2018 to ...

Finding natural ways to increase glucagon-like peptide-1, otherwise known as GLP-1, can be very beneficial in helping treat type 2 diabetes and obesity.

The following is a summary of “Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for ...

Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes.

A high-protein diet can aid weight loss and overall health if you consume about 1 to 1.5 grams of protein per pound of body weight per day. Here’s how (and why) it helps shed excess weight.

GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

From 2008-2011 to 2020-2023, there was an increase in the prevalence of obesity among youth and adults with type 1 diabetes, and glucagon-like peptide 1 receptor agonist (GLP-1 RA) prescriptions also ...

As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less ...